Navigating Personalized Approaches With Radiation Therapy for Early-Stage Breast Cancer
Robert W. Mutter, MD, discusses personalized treatment approaches with radiation and endocrine therapy with
Robert W. Mutter, MD, discusses personalized treatment approaches with radiation and endocrine therapy with
The American Cancer Society aims to enroll over 100,000 Black, cancer-free women between the ages of 25 and 55 and follow them for three decades.
In a retrospective cohort study (SPOTLIGHT), investigators found that a substantial proportion of patients with unresectable stage III NSCLC did not receive consolidation durvalumab after…
Longtime Fred Hutchinson Cancer Center supporters Carl and Renee Behnke have committed $15M to help launch an ambitious new comprehensive campaign. In recognition, the South…
Summary. Combination immune-checkpoint inhibition with chemotherapy is a clinical standard, yet concurrent administration may limit the full benefit of immunotherapy by blunting the proliferation and…
Patients with CLL/SLL who received second-line venetoclax experienced monthly cost savings compared with those who received a second-line BTK inhibitor.
Miriam Merad was named dean for Translational Research and Therapeutic Innovation of the Icahn School of Medicine at Mount Sinai. To access this subscriber-only content…
Sima Porten, MD, MPH, discusses the rationale for the phase 3 SunRISe-5 study of TAR-200 in non-muscle invasive bladder cancer and unmet needs in this…
Learn more about this new series with SSO President, Dr. Ronald DeMatteo, providing quick updates on important SSO initiatives through interviews with variou…
Registered nurses discuss research related to agents like ciltacabtagene autoleucel presented at the 2024 Oncology Nursing Society Congress.
Online resources about liquid biopsies have several deficits that could prevent patients from learning about the test and better understanding , according to findings published…